SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-518355
Filing Date
2012-12-28
Accepted
2012-12-28 16:40:55
Documents
4
Period of Report
2012-12-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d457250d8k.htm 8-K 20853
2 PRESS RELEASE d457250dex991.htm EX-99.1 45451
3 GRAPHIC g457250g40w69.jpg GRAPHIC 4836
4 GRAPHIC g457250g56c54.jpg GRAPHIC 3104
  Complete submission text file 0001193125-12-518355.txt   78713
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 121291360
SIC: 2834 Pharmaceutical Preparations